These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20198769)

  • 21. CDX2 immunoreactivity in primary and metastatic ovarian mucinous tumours.
    Fraggetta F; Pelosi G; Cafici A; Scollo P; Nuciforo P; Viale G
    Virchows Arch; 2003 Dec; 443(6):782-6. PubMed ID: 14576939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas.
    Perysinakis I; Minaidou E; Leontara V; Mantas D; Sotiropoulos GC; Tsipras H; Zografos GN; Margaris I; Kouraklis G
    Int J Surg Pathol; 2017 Feb; 25(1):31-40. PubMed ID: 27543509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge.
    Roy S; Smith MA; Cieply KM; Acquafondata MB; Parwani AV
    Diagn Pathol; 2012 Nov; 7():151. PubMed ID: 23121893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma.
    Loy TS; Calaluce RD; Keeney GL
    Mod Pathol; 1996 Nov; 9(11):1040-4. PubMed ID: 8933513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LEF-1 is frequently expressed in colorectal carcinoma and not in other gastrointestinal tract adenocarcinomas: an immunohistochemical survey of 602 gastrointestinal tract neoplasms.
    Kermanshahi TR; Jayachandran P; Chang DT; Pai R
    Appl Immunohistochem Mol Morphol; 2014; 22(10):728-34. PubMed ID: 25394300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of REG4 in ovarian mucinous tumors.
    Huang Q; Chen X; Lu W; Lai M; Lu B
    Appl Immunohistochem Mol Morphol; 2014 Apr; 22(4):295-301. PubMed ID: 23958547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma.
    Kennedy MT; Jordan RC; Berean KW; Perez-Ordoñez B
    J Clin Pathol; 2004 Sep; 57(9):932-7. PubMed ID: 15333652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of CDX-2 in distinguishing between primary and secondary (intestinal) mucinous ovarian carcinoma: an immunohistochemical comparison of 43 cases.
    Raspollini MR; Amunni G; Villanucci A; Baroni G; Taddei A; Taddei GL
    Appl Immunohistochem Mol Morphol; 2004 Jun; 12(2):127-31. PubMed ID: 15354737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Sinonasal adenocarcinomas reviewed. Prognostic value of WHO 2005 histological classification].
    El Ayoubi A; Poizat F; Garrel R; Costes V; Guerrier B; Essakalli L; Kzadri M; Crampette L
    Ann Otolaryngol Chir Cervicofac; 2009 Sep; 126(4):175-81. PubMed ID: 19591973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CDX-2 expression in pulmonary fine-needle aspiration specimens: a useful adjunct for the diagnosis of metastatic colorectal adenocarcinoma.
    Levine PH; Joutovsky A; Cangiarella J; Yee H; Simsir A
    Diagn Cytopathol; 2006 Mar; 34(3):191-5. PubMed ID: 16470859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CDX-2, cytokeratin 7 and cytokeratin 20 immunohistochemical expression in the differential diagnosis of primary adenocarcinomas of the sinonasal tract.
    Franchi A; Massi D; Palomba A; Biancalani M; Santucci M
    Virchows Arch; 2004 Jul; 445(1):63-7. PubMed ID: 15175880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary pulmonary adenocarcinoma with intestinal differentiation mimicking metastatic colorectal carcinoma: case report and review of literature.
    Li HC; Schmidt L; Greenson JK; Chang AC; Myers JL
    Am J Clin Pathol; 2009 Jan; 131(1):129-33. PubMed ID: 19095576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of the intestinal marker Cdx2 in secondary adenocarcinomas of the colorectum.
    Groisman GM; Bernheim J; Halpern M; Brazowsky E; Meir A
    Arch Pathol Lab Med; 2005 Jul; 129(7):920-3. PubMed ID: 15974817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BRAF-mutated microsatellite stable colorectal carcinoma: an aggressive adenocarcinoma with reduced CDX2 and increased cytokeratin 7 immunohistochemical expression.
    Landau MS; Kuan SF; Chiosea S; Pai RK
    Hum Pathol; 2014 Aug; 45(8):1704-12. PubMed ID: 24908142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Detection of CDX-2, CK7 and CK20 in primary and metastatic ovarian carcinoma].
    Yuan ZF; Shi HR; Sun HM; Li WC
    Zhonghua Bing Li Xue Za Zhi; 2007 Aug; 36(8):555-6. PubMed ID: 17980105
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunohistochemical characterization of appendiceal mucinous neoplasms and the value of special AT-rich sequence-binding protein 2 in their distinction from primary ovarian mucinous tumours.
    Strickland S; Parra-Herran C
    Histopathology; 2016 Jun; 68(7):977-87. PubMed ID: 26542609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites.
    Lagendijk JH; Mullink H; Van Diest PJ; Meijer GA; Meijer CJ
    Hum Pathol; 1998 May; 29(5):491-7. PubMed ID: 9596273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
    McCluggage WG; Shah R; Connolly LE; McBride HA
    Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The morphologic spectrum of ovarian metastases of appendiceal adenocarcinomas: a clinicopathologic and immunohistochemical analysis of tumors often misinterpreted as primary ovarian tumors or metastatic tumors from other gastrointestinal sites.
    Ronnett BM; Kurman RJ; Shmookler BM; Sugarbaker PH; Young RH
    Am J Surg Pathol; 1997 Oct; 21(10):1144-55. PubMed ID: 9331286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CDX2 immunostaining as a gastrointestinal marker: expression in lung carcinomas is a potential pitfall.
    Mazziotta RM; Borczuk AC; Powell CA; Mansukhani M
    Appl Immunohistochem Mol Morphol; 2005 Mar; 13(1):55-60. PubMed ID: 15722794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.